NasoShield Study of Safety and Immunogenicity

NCT03352466 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
145
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Altimmune, Inc.